| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.27 | 0.08 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.5 | 0.08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.08 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |